A simple drink before surgery might ease the Body's stress — a trial puts it to the test
NCT ID NCT07723391
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial tests whether giving liver donors a carbohydrate drink a few hours before surgery can lower lactate levels, a marker of metabolic stress. Half of the 70 participants will receive the drink, while the other half will follow standard fasting. Researchers will measure lactate at several points during and after the operation to see if the drink helps the body handle the procedure better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a standardized oral carbohydrate drink (maltodextrin solution) given 2-4 hours before surgery
- What this could lead to
- If it works, this simple drink could become a standard way to help liver donors recover with less metabolic stress.
- What could go wrong
- This is a small, early-stage trial with only 70 participants. The benefit may be small or not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 to 50 years Either gender Scheduled for elective donor hepatectomy Exclusion Criteria: * Known metabolic disorders Pre-existing liver dysfunction
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Donor hepatectomy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shifa International Hospital
Islamabad, Federal, 44000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.